Implications of immunosuppressive therapy in terms of adverse effects, monitoring, and preventative measures

Overview

Long-term immunosuppressive therapy (for transplant, autoimmune disease, or severe inflammatory skin disease itself) carries substantial dermatological implications - most importantly a markedly increased risk of skin malignancy - requiring specific monitoring and preventive measures
Cumulative immunosuppression duration and intensity correlate with skin cancer risk, particularly relevant in long-term solid organ transplant recipients, who face substantially elevated squamous cell carcinoma risk compared with the general population

Reduced immune surveillance impairs normal immune-mediated clearance of UV-damaged/dysplastic keratinocytes and of oncogenic viral infections (HPV, contributing to some skin cancers) - explaining the markedly increased risk of squamous cell carcinoma specifically (a larger relative risk increase than basal cell carcinoma) in chronically immunosuppressed patients

Regular, structured skin cancer screening (see skin cancer screening in the immunosuppressed) is essential in this population, at a frequency and intensity greater than general population screening
Monitor for other immunosuppression-related dermatological effects: increased infection susceptibility (viral warts, fungal infection), and specific drug-related skin effects (e.g. calcineurin inhibitor-associated effects)

Preventive measures: rigorous sun protection counselling (arguably even more important than in the general population given the markedly elevated risk), and consideration of chemoprevention strategies (e.g. nicotinamide, acitretin in selected high-risk transplant patients) alongside regular surveillance
Where feasible, minimising immunosuppression intensity (balanced against the risk of graft rejection/underlying disease flare) can reduce skin cancer risk, though this must be weighed carefully against the primary indication for immunosuppression

Squamous cell carcinoma (disproportionately increased risk), solid organ transplant recipients, chronic sun exposure interaction with immunosuppression, HPV-related skin lesions

The skin cancer risk increase with chronic immunosuppression disproportionately affects squamous cell carcinoma relative to basal cell carcinoma - a frequently tested, clinically relevant distinction from the more even SCC:BCC ratio seen in immunocompetent sun-damaged populations

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.